Int J Pharm Pharm Sci, Vol 9, Issue 12, 78-81Original Article


STRUCTURE CHARACTERIZATION AND EVALUATION POTENTIAL OF ANTIMICROBIAL EXTRACTS FROM PHELLINUS LINTEUS AGAINST SKIN INFECTIOUS PATHOGENS, STAPHYLOCOCCUS EPIDERMIDIS ATCC12228 AND PROPIONIBACTERIUM ACNES DMST14916

SURACHAI TECHAOEI*, PATTARANUT EAKWAROPAS, KHEMJIRA JARMKOM, WARACHATE KHOBJAI

Thai Traditional Medicine College, Rajamangala University of Technology Thanyaburi, Pathum Thani 12130 Thailand
Email: surchai_te@rmutt.ac.th

Received: 08 Apr 2017 Revised and Accepted: 02 Nov 2017


ABSTRACT

Objective: The objective of this study was to investigate the antimicrobial activity of Phellinus linteus against skin infectious pathogens, Staphylococcus epidermidis ATCC12228 and Propionibacterium acnes DMST 14916.

Methods: Fungal fruiting bodies were extracted with 95% ethanol and ethyl acetate, and then, vaporized. The antimicrobial activities were determined by the disc diffusion method against Propionibacterium acnes DMST 14916 and Staphylococcus epidermidis ATCC12228 skin infectious pathogens. A minimum inhibitory concentration (MIC) and a minimum bactericidal concentration (MBC) for those crude extracts were determined. Finally, the chemical profile of crude extract was determined by using thin layer chromatography and GC-MS.

Results: The result demonstrated that the ethanolic extraction had more active fractions with an MIC of 0.5 mg/ml against the growth of Propionibacterium acnes DMST 14916 and Staphylococcus epidermidis ATCC12228 and also showed a minimum inhibitory concentration (MBC) at a concentration of 1.0 mg/ml, while ethyl acetate-based solvents failed to develop on TLC according to Retention factor (Rf) values of 0.71-0.76. The GC-MS was applied to investigate the chemical profile of crude extract of Phellinus linteus, revealing a component of hexadecanoic acid and 9, 12-octadecadienoic acid.

Conclusion: Phellinus linteus fruiting body extracts have great potential as antimicrobial compounds against Propionibacterium acnes DMST 14916 and Staphylococcus epidermidis ATCC12228. Thus, they can be used in the treatment of infectious diseases caused by bacterial pathogens.

Keywords: Antimicrobial activity, Phellinus linteus, Staphylococcus epidermidis, Propionibacterium acnes, MIC, MBC


INTRODUCTION

In recent years, the increasing antimicrobial resistance called superbugs has driven a critical need to develop a novel antimicrobial agent [1]. The multi-drug resistant strains do not only occur through nosocomial infection, but also in the public condition [2] especially bacterial resistance in sexually transmitted infections [3], Escherichia coli, Klebsiella pneumonia, Haemophilus sp., vancomycin-resistant Enterococcus (VRE), Methicillin-resistant Staphylococcus aureus (MRSA), as well as opportunistic pathogens [4]. The main reason for the antibiotic-resistant crisis can be the overuse of broad-spectrum antibiotics. In addition, drugs used in livestock and agriculture badly affect the environmental microorganisms [5]. However, several novel antibiotic agents that are most suitable for use in the hospital environment have been developed to combat both Gram-positive and Gram-negative bacteria, especially screening active biomolecules with effective pharmacologic properties and drug safety with a return to treatment using traditional medicines.

Medicinal mushrooms in the class Basidiomycetes, Phellinus linteus (Berk. and M. A Curtis) Teng, called Krathin Phiman in Thai, have been widely used as herbs in China, Japan, Korea, and Thailand since the ancient time. Phellinus linteus has been found to produce several biologically active compounds that are usually associated with cell walls. These compounds have been suggested to contribute to the enhancement of immunity [6] and tumour-retarding effect, antioxidant [7-9], anti-inflammatory [10] and antimicrobial activities, [11] and good therapeutic effects on diabetes and obesity [12].

Hypothetically, the Phellinus linteus extract may be a reason that plays a significant role in the treatment of skin infectious pathogens. Thus, this study was conducted to analyze antimicrobial activities and investigate the chemical profile of crude extract compared with original positive drugs for an inhibition of microbial growth.

MATERIALS AND METHODS

Preparation of mushroom extract

The fruiting bodies of Phellinus linteus were obtained from a folk medicine company in Thailand. The extraction of the mushrooms was conducted by macerating the mushrooms in 95% ethanol and ethyl acetate at 1:20 (w/v) for 7 d. After the maceration, the extract was filtered through Whatman No. 1, and the filtrate was evaporated using an evaporator. The residue was extracted two times. Then, the extract was combined and evaporated to a constant weight. The crude extract was calculated for the percentage yield and kept at-20 °C for further investigation.

Preparation of inoculums

Both bacterial strains S. epidermidis ATCC12228 and P. acnes DMST 14916 were obtained from the National Institute of Health, Thailand. The tested bacteria were inoculated in nutrient broth and incubated for 16-18 h at 37 °C in aerobic condition for S. epidermidis ATCC12228 and in anaerobic condition for P. acnes DMST 14916. A 0.5 McFarland standard was used to adjust the turbidity corresponding to 107-108 CFU/ml.

Antimicrobial assay

The disc diffusion method was used to determine the antibacterial activity of the P. linteus extracts by using nutrient agar (NA). A fresh bacterial suspension with the turbidity corresponding to 107-108 CFU/ml was spread on NA plates with sterile cotton swabs.

The disc diffusion assay was completed by adding the tested crude extract which dissolved in dimethyl sulfoxide (DMSO) solution at an initial concentration of 100 mg/ml onto the 6 mm disc. The Petri plates were then incubated at 37 °C for 24 h in an incubator. The experiment was conducted in triplicate and the mean diameter of the zone of inhibition was recorded in millimetres (mm). The results were represented by mean±standard deviation [13].

Determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC)

To assess the MIC and MBC of mushroom crude extracts, the serial two-flow dilution was carried out with the disc diffusion assay. The MIC represented the lowest concentration showing an inhibition zone; the MBC was determined by subculturing which showed no bacterial growth on the agar plates after incubated at 37 °C for 24 h in an incubator. The lowest concentration that did not show bacterial growth was defined as an MBC value. The experiment was conducted in triplicate, and the mean diameter of the zone of inhibition was recorded in millimetres (mm). Erythromycin was used as a positive control, and dimethyl sulfoxide (DMSO) solution was used as a negative one. All experiments were performed in triplicate. The results were represented by mean±standard deviation [14].

Thin layer chromatography analysis

TLC was carried out using aluminium silica gel 60GF254 of a thickness of 0.2 mm, (Germany). Standard chromatograms of P. linteus extract were prepared by applying a 20 µl extract solution to a silica gel TLC plate and developed with chloroform/methanol (1:1; v/v) under saturated conditions. The chromatograms were detected by UV-light (254 nm and 365 nm) and the colour reaction with a 5% sulfuric acid-ethanol spraying solution after heating at 100 °C.

Gas chromatography-mass spectrometry analysis

GC-MS analysis tests for the fruiting body extract composition analysis were performed on an Agilent 789 GC system instrument equipped with HP-5MS (5% diphenyl 95% dimethylpolysiloxane) column (30 m x 0.25 mm, 0.25 µm) and interfaced to a 5975C inert XL MSD with Triple-Axis Detector. A volume injection of 2 µl was employed (a split ratio of 10:1) at an injector temperature of 250 °C. The column temperature was increased from 60 °C to 250 °C at a rate of 5 °C/min. The outlet temperature was 280 °C. Mass spectra were taken at 70 Da. and Ms transfer line temperature of 250 °C. The components of the extract were identified by comparison of fragmentation patterns in mass spectra with those stored on the spectrometer database and reported in the literature. The relative percentage of the individual components was calculated from the GC peak areas [15].

Identification of bioactive constituents

Interpretation on Mass-spectrum GC-MS was carried out by using the database of National Institute Standard and Technology (NIST) containing more than 62,000 patterns. The spectrum of the unknown components was compared with the spectrum of the known components stored in the NIST library. The name, molecular formula, weight and chemical structure of the components of the test materials were ascertained [16].

Statistical analysis

The results of the data experiments were expressed in mean±SEM (Standard Error of Mean) for groups (n=3).

RESULTS AND DISCUSSION

Antibacterial activities

The antimicrobial activity results of Phellinus linteus fruiting body extracts are summarized by the paper-disc diffusion method as shown in table 1. The results of the disc diffusion method in terms of the size of inhibition zone (mm) for the extracts were compared against microorganisms studied. The highest inhibitory activity was determined against S. epidermidis ATCC12228 and P. acnes DMST14916 in a clearing zone of 15.67±1.15 and 12.67±1.53 mm, whereas ethyl acetate extract showed no inhibition zone.

In a previous study, numerous Phellinus mushroom extract was reported as having an antimicrobial activity against Gram-positive bacteria, B. cereus, B. subtilis and S. aureus [17]. The mushroom in the fraction of methanol extract demonstrated a good activity against MRSA [18, 19]. In addition, the sesquiterpenoid, a bioactive compound from Phellinus species such as P. fastuosus, P. merrillii, P. aureobruneus, P. crocatus, P. lloydii, and P. sublinteus had an effective antibacterial activity against different microorganisms such as Acinetobacter calcoacetic NCIB2886, B. subtilis NCIM2010, Candida albicans MTCC 1637, C. albicans MTCC 3017, C. albicans ATCC 2091, Escherichia coli MTCC 724, E. coli MTCC 739, E. coli ATCC 2046, Klebsiella pneumonia MTCC 432, Proteus mirabilis MTCC1429, Pseudomonas aeruginosa ATCC2036, and S. aureus HAL 2079, respectively [20].

Table 1: Bacterial activities of the crude extract of Phellinus linteus

Bacterial strains Inhibition zone (mm.)
EtOH EtOAC +ve -ne
S. epidermidis ATCC12228 15.33±0.58 - 22.67±0.58 -
P. acnes DMST14916 12.67±1.53 - 24.00±0.00 -

+ve: positive control (10.0 mg/ml erythromycin);-ne: negative control (10% DMSO); statistical analysis as mean±sd.

Bacteriostatic and bactericidal effect

In terms of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) against S. epidermidis ATCC12228 and P. acnes DMST14916, a lower MIC was observed in table 2. The MIC test indicated that the extract of the P. linteus fruiting body exhibited a minimal value of MIC (0.5 mg/ml) against S. epidermidis. MBC was found to have a concentration of 1.0 mg/ml with all strains. According to a previous study, P. gilvus aqueous extract showed MIC against L. plantarum ACC14917, K. pneumonia ATCC 10031 and E. coli ATCC25922 at concentrations of 45.0, 90.0 and 360.0 mg/l, respectively, while those of MBC against them were 90, 180, and 720 mg/l, respectively [21].

Chemical characterization of Phellinus linteus

Thin layer chromatography analysis

Developed TLC plates with visualized spots were observed. There were dark blue spots of extracts under 365 nm and 254 nm UV light (Rf ≈ 0.71-0.76). After colourized by 5% sulfuric acid-ethanol solution, polar spots appeared in the same UV light positions.

Gas chromatography-mass spectrometry analysis

The active principles with their retention time (RT), molecular formula, molecular weight (MW), concentration (Peak area %) and the chemical structure were analyzed.

Table 3 shows the components present in the unfractionated ethanolic extract as identified by GC-MS. Two components comprising about 98.50% of the total ethanolic extract were identified with hexadecanoic acid, ethyl ester (C8H36O2, 74.9%) forming the major constituent and 9,12-octadecadienoic acid, ethyl ester (C20H36O2, 23.6%), respectively.

In fig. 1, the peak at a retention time of 23.576 min has a mass spectrum data consistent with hexadecanoic acid, ethyl ester. The mass spectrum exhibited a parent ion at m/z 284 consistent with the molecular formula C8H36O2. In addition, in fig. 2, the peak at a retention time of 30.438 min has a mass spectrum data consistent with 9,12-octadecadienoic acid, ethyl ester. The mass spectrum exhibited a parent ion at m/z 308 consistent with the molecular formula C20H36O2.

Table 2: Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of Phellinus linteus to inhibit 100% of the bacterial growth

Bacterial strains Concentration (mg/ml)
MIC MBC
S. epidermidis ATCC12228 0.5±0.00 1.0±0.00
P. acnes DMST14916 0.5±0.00 1.0±0.00

MIC: the minimum inhibitory concentration; MBC: the minimum bactericidal concentration (mean±SD)

Table 3: Characterized chemical constituents of P. linteus extracts

Compound RT PT MW MF
Hexadecanoic acid, Ethyl ester 23.57 74.90 284.27 C8H36O2
9,12-Octadecadienoic acid, Ethyl ester 30.483 23.60 308.27 C20H36O2

RT: retention time (min); PT: percentage (%); MW: molecular weight; MF: molecular formula

Fig. 1: Mass spectrum of hexadecanoic acid, ethyl ester

Fig. 2: Mass spectrum of 9,12-octadecadienoic acid, ethyl ester

Previously, many species of Phellinus were reported as producing bioactive compounds like polysaccharides [22], flavones, triterpenes, aromatic acid, and amino acids [14]. These results were similar to those reported by Chinese scientists discovering active compounds from Phellinus species including palmitoleic acid, linoleic acid, oleic acid, hexadecanoic acid, and stearic acid [23].

CONCLUSION

According to the study, the results revealed that the ethanolic extract of Phellinus linteus fruiting bodiy possessed measurable antimicrobial activities against both S. epidermidis ATCC12228 and P. acnes DMST14916. The results also showed MIC and MBC at concentrations of 0.5 mg/ml and 1.0 mg/ml, respectively. However, in order to use these mushrooms properly in medicine, more detailed studies need to be conducted.

ACKNOWLEDGEMENT

We would like to thank the Rajamangala University of Technology Thanyaburi for its financial support and Thai Traditional Medicine College, RMUTT for all facilities used in the conduct of this study.

CONFLICT OF INTERESTS

Declared none

REFERENCES

  1. B Spellberg R, Guidos D, Gilbert J, Bradly HW, Boucher WM, Scheld JG, et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the infectious diseases society of America. Clin Infect Dis 2008;46:155-64.

  2. Talbot GH, Bradley J, Edwards JE, Gilbert DJ, Scheld M, Bartlet JG. Bad bugs need drugs: and update on the development pipeline from the antimicrobial availability task force of the infectious diseases society of America. Clin Infect Dis 2006;42:657-68.

  3. Unemo M, Jensen JS. Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium. Nat Rev Urol 2017;14:139-52.

  4. Giamarellou H. Treatment options for multidrug-resistant bacteria. Expert Rev Anti Infect Ther 2006;4:601-8.

  5. Gootz TD. The global problem of antibiotic resistance. Rcrit Rev Immunol 2010;30:79-93.

  6. Lindequist U, Niedermeyer TH, Julich WD. The pharmacological potential of mushrooms. J Evidence-Based Complementary Altern Med 2005;2:285-99.

  7. Matsuba S, Matsuno H, Sakuma, Komatsu MY. Phellinus linteus extract augments the immune response in mitomycin C-induced immunodeficient mice. J Evidence-Based Complementary Altern Med 2008;5:85-90.

  8. Yang BK, Hwang SL, Yun IK, Do EJ, Lee WH, Jung YM, et al. Antitumor effects and immunomodulating activities of Phellinus linteus extract in a CT-26 cell-injected colon cancer mouse model. Mycobiology 2009;37:128-32.

  9. Seklic DS, Stankovic MS, Milutinovic MG, Topuzovic MD, Stajn AS, Markovic SD. Cytotoxic, antimigratory, pro-and antioxidative activities of extracts from medicinal mushrooms on colon cancer cell lines. Arch Biol Sci 2016;68:93-105.

  10. Lin CJ, Lien HM, Chang HY, Huang CL, Liu JJ, Chang YC, et al. Biological evaluation of Phellinus linteus-fermented broths as anti-inflammatory agents. J Biosci Bioeng 2014;118:88-93.

  11. Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: a review. J Pharm Anal 2016;6:71-9.

  12. Singh G, Kumar P. Antibacterial potential of alkaloids of Withania somnifera L. and Euphorbia hirta L. Int J Pharm Pharm Sci 2012;4:78-81.

  13. Tamijothi E, Ravichandiran V, Chandrasekhar N, Suba V. Pharmacognostic and preliminary phytochemical screening of leaves of Tecomaria capensis. Asian J Plant Sci Res 2011;1:34-40.

  14. Chen H, Tian T, Miao H, Zhao YY. Traditional uses, fermentation, phytochemistry and pharmacology of Phellinus linteus: a review. Fitoterapia 2016;113:6-26.

  15. Valgas C, Souza SM, Smania EFA, Smania AJ. Screening methods to determine antibacterial activity of natural products. Br J Microbiol 2007;38:369-79.

  16. Carbonero ER, Ruthes C, Freitas CS, Utrilla P, Gálvez J, Silva EV, et al. Chemical and biological properties of a highly branched β-edible mushroom Pleurotus sajor-caju. Carbohydr Polym 2012;90:814-9.

  17. Alves MJ, Ferreira ICFR, Dias J, Teixeira V, Martins A, Pintado M. A review on antimicrobial activity of mushroom (basidiomycetes) extracts and isolated compounds. Planta Med 2012;78:1707-18.

  18. Hearst T, Helson D, Mccollum G, Millar BC, Maeda Y, Goldsmith CE, et al. An examination of antimicrobial and antifungal properties of constituents of Shiitake (Lentinula edodes) and Oyster (Pleurotus ostreatus) mushrooms. Complementary Ther Clin Practice 2009;15:5-7.

  19. Hur JM, Yang CH, Han SH, Lee SH, You YO, Park C, et al. Antimicrobial effect of Phellinus linteus against methicillin-resistant Staphylococcus aureus. Fitoterapia 2004;75:603-5.

  20. Sonawane H, Bhosle S, Vaidya J, Sharif A, Garad S, Bapat G, et al. In vitro evaluation of sesquiterpenoid extracts of phellinus samples from Western Ghats of Maharashtra for antimicrobial activity. J Phytol 2011;3:35-7.

  21. Sittiwet C, Puangpronpitag D. Antibacterial activity of Phellinus gilvus aqueous extract. Int J Pharmacol 2008;4:500-2.

  22. Hwang HJ, Kim SW, Xu CP, Choi JW, Yun JW. Production and molecular characteristics of four groups of exopolysaccharides from submerged culture of Phellinus gilvus. J Appl Microbiol 2003;94:708-19.

  23. Deng K, Zhang Y, Xie L, Peng W, Gan B, Ren Z. Simultaneous determination of five fatty acids in Phellinus sp. by high-performance liquid chromatography with photodiode-array detection. J Med Plants Res 2011;5:3084-9.



About this article

Title

STRUCTURE CHARACTERIZATION AND EVALUATION POTENTIAL OF ANTIMICROBIAL EXTRACTS FROM PHELLINUS LINTEUS AGAINST SKIN INFECTIOUS PATHOGENS, STAPHYLOCOCCUS EPIDERMIDIS ATCC12228 AND PROPIONIBACTERIUM ACNES DMST14916

Keywords

Antimicrobial activity, Phellinus linteus, Staphylococcus epidermidis, Propionibacterium acnes, MIC, MBC

DOI

10.22159/ijpps.2017v9i12.19032

Date

01-12-2017

Additional Links

Manuscript Submission

Journal

International Journal of Pharmacy and Pharmaceutical Sciences
Vol 9, Issue 12, 2017 Page: 78-81

Online ISSN

0975-1491

Statistics

51 Views | Downloads

Authors & Affiliations

Surachai Techaoei
Thai Traditional Medicine College, Rajamangala University of Technology Thanyaburi, Pathum Thani 12130 Thailand
Thailand

Pattaranut Eakwaropas
Thai Traditional Medicine College, Rajamangala University of Technology Thanyaburi, Pathum Thani 12130 Thailand

Khemjira Jarmkom
Thai Traditional Medicine College, Rajamangala University of Technology Thanyaburi, Pathum Thani 12130 Thailand

Warachate Khobjai
Thai Traditional Medicine College, Rajamangala University of Technology Thanyaburi, Pathum Thani 12130 Thailand


Article Tools



Refbacks

  • There are currently no refbacks.